ReviewDrugs2005
Medication errors: hospital pharmacist perspective.
Review in Drugs, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.BMC health services research · 2024Article
- Investigating safe nursing care and medication safety competence in nursing students: a multicenter cross-sectional study in Iran.BMC nursing · 2024Article
- Investigating physicians' views on non-formulary prescribing: a qualitative study using the theoretical domains framework.International journal of clinical pharmacy · 2023Article
- Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward.Computational and structural biotechnology journal · 2023Article
- End-users feedback and perceptions associated with the implementation of a clinical-rule based Check of Medication Appropriateness service.BMC medical informatics and decision making · 2022Article
- Cost-effectiveness of check of medication appropriateness: methodological approach.International journal of clinical pharmacy · 2022Article
- Review
- The Effect of Occupational Stress on the Quality of Life of Pharmacists in Saudi Arabia.Risk management and healthcare policy · 2021Article
- Job satisfaction, work commitment and intention to leave among pharmacists: a cross-sectional study.BMJ open · 2019Article
- Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance.BMC medical informatics and decision making · 2019Observational
- Investigating factors associated with not reporting medical errors from the medical team's point of view in Jahrom, Iran.Global journal of health science · 2014Article
- Nature and frequency of medication errors in a geriatric ward: an Indonesian experience.Therapeutics and clinical risk management · 2014Article
- Introduction of pharmaceutical expertise in a palliative care team in Sweden.Pharmacy world & science : PWS · 2010Article
- Application of the Bow-Tie model in medication safety risk analysis: consecutive experience in two hospitals in the Netherlands.Drug safety · 2009Article
- Raising the awareness of inpatient nursing staff about medication errors.Pharmacy world & science : PWS · 2008Article
- Preventing medication errors in community pharmacy: root-cause analysis of transcription errors.Quality & safety in health care · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years medication error has justly received considerable attention, as it causes substantial mortality, morbidity and additional healthcare costs. Risk assessment models, adapted from commercial aviation and the oil and gas industries, are currently being developed for use in clinical pharmacy. The hospital pharmacist is best placed to oversee the quality of the entire drug distribution chain, from prescribing, drug choice, dispensing and preparation to the administration of drugs, and can fulfil a vital role in improving medication safety. Most elements of the drug distribution chain can be optimised; however, because comparative intervention studies are scarce, there is little scientific evidence available demonstrating improvements in medication safety through such interventions. Possible interventions aimed at reducing medication errors, such as developing methods for detection of patients with increased risk of adverse drug events, performing risk assessment in clinical pharmacy and optimising the drug distribution chain are discussed. Moreover, the specific role of the clinical pharmacist in improving medication safety is highlighted, both at an organisational level and in individual patient care.
Indexed as
Identifiers
16114974What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.